AMBEV S.A. current report, Q1 FY2018

Business Context and Reporting Period

This Form 6-K filing by AMBEV S.A. covers the month of February 2018, with the report signed on March 9, 2018. The document serves as a consolidated report of securities transactions by the Board of Directors, Management, and related persons, filed in compliance with Article 11 of CVM Instruction # 358/2002.

Key Financial Metrics

The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. It exclusively details equity ownership changes and transaction volumes for insiders.

Group Initial Common Shares Final Common Shares Initial ADRs Final ADRs
Board of Directors 5,497,407 5,448,122 361,530 368,949
Group and Related Persons 31,006,362 31,006,362 29,488 29,488
Management 7,225 7,225 N/A N/A

Material Changes

Material changes occurred within the Board of Directors' holdings during February 2018:

  • Resignation: 113,848 Common Shares were removed from the balance (valued at R$ 0.00 in the filing).
  • Sales: 10,820 Common Shares were sold via Itaú Corretora for a total volume of R$ 233,987.00. Prices ranged from R$ 21.57 to R$ 22.28.
  • Elections: 75,383 Common Shares and 7,419 ADRs were added to the balance (valued at R$ 0.00/USD 0.00 in the filing).
  • Net Result: The Board's Common Share count decreased by 49,285 shares, while ADR holdings increased by 7,419.

No transactions were reported for the "Group and Related Persons" or "Management" categories during this period.

Guidance, Outlook, and Risks

The filing text does not provide guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of insider trading activity.

Investor Verification Checklist

  • Verify the identity of the Board members involved in the resignation and election of shares to understand the context of the net decrease in holdings.
  • Confirm the total number of shares outstanding to assess the significance of the 0.0350% ownership stake held by the Board.
  • Review the specific dates of the sales (February 1 and February 9) against market price movements to evaluate trading timing.
  • Check subsequent filings to see if the "Group and Related Persons" holdings remained static or if further changes occurred.